FR Pharma Consulting ApS — Credit Rating and Financial Key Figures
CVR number: 44253569
Naverland 1 C, 2600 Glostrup
Income statement (kDKK)
2024 | |
|---|---|
| Fiscal period length | 12 |
| Net sales | |
| Gross profit | 750.08 |
| Employee benefit expenses | - 485.48 |
| EBIT | 264.59 |
| Other financial expenses | -3.69 |
| Pre-tax profit | 260.90 |
| Income taxes | -57.55 |
| Net earnings | 203.35 |
Assets (kDKK)
2024 | |
|---|---|
| Intangible assets total | |
| Tangible assets total | |
| Investments total | |
| Long term receivables total | |
| Inventories total | |
| Current trade debtors | 205.63 |
| Short term receivables total | 205.63 |
| Cash and bank deposits | 227.02 |
| Cash and cash equivalents | 227.02 |
| Balance sheet total (assets) | 432.64 |
Equity and liabilities (kDKK)
2024 | |
|---|---|
| Share capital | 40.00 |
| Profit of the financial year | 203.35 |
| Shareholders equity total | 243.35 |
| Non-current deferred tax liabilities | 57.55 |
| Non-current liabilities total | 57.55 |
| Other non-interest bearing current liabilities | 131.74 |
| Current liabilities total | 131.74 |
| Balance sheet total (liabilities) | 432.64 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.